In South San Francisco, Genentech showed that recombinant DNA technology could transform medicine and create therapies once ...
Healthcare stocks are attractive in a choppy market. These funds, focusing on the broader sector, drugmakers, and biotechs, ...
The Investment Committee give you their top stocks to watch for the second half.
Nearly 1 million bottles of the medication are being recalled because they may contain a foreign substance, according to an ...
News Nation on MSN
Common kidney, heart meds recalled due to ‘foreign substance’
The FDA reports state the recalls affect more than 944,000 bottles of the medications.
By Jonathan Stempel July 1 (Reuters) - A federal judge on Wednesday blocked Colorado from capping the price of Amgen's ...
Amgen has issued a voluntary recall for nearly 1 million bottles of the heart medication Corlanor (ivabradine) due to possible contamination. The nationwide recall was issued by the company on June 4 ...
In 2024, the Colorado Prescription Drug Affordability Review Board declared Enbrel unaffordable, and last year it set an ...
Pharmalittle: We’re reading about a court win for Amgen, Novo seeking supplier discounts, and more
A U.S. Centers for Medicare & Medicaid Services 18-month ​trial program will offer for the first time Novo Nordisk’s Wegovy ...
Here’s how to tell if your prescriptions are affected—and what to do about it.
Alphabet may be the Dow's newest member, but these three dividend-paying Dow stocks look like the better buys for income ...
4don MSN
Drug manufacturer recalls more than 944,000 bottles of heart and kidney medications nationwide
Over 900,000 bottles of heart and kidney medications are being recalled from retailers nationwide due to possible ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results